These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11008004)

  • 1. Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms.
    Sabina RL; Mahnke-Zizelman DK
    Pharmacol Ther; 2000; 87(2-3):279-83. PubMed ID: 11008004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of N-terminal sequences in human AMP deaminase isoforms that influence contractile protein binding.
    Mahnke-Zizelman DK; Sabina RL
    Biochem Biophys Res Commun; 2001 Jul; 285(2):489-95. PubMed ID: 11444869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent N-terminal regions in AMP deaminase and isoform-specific catalytic properties of the enzyme.
    Bausch-Jurken MT; Sabina RL
    Arch Biochem Biophys; 1995 Aug; 321(2):372-80. PubMed ID: 7646062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of functional domains in AMPD1 by mutational analysis.
    Gross M; Morisaki H; Morisaki T; Holmes EW
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1010-7. PubMed ID: 7802626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.
    Mahnke-Zizelman DK; Tullson PC; Sabina RL
    J Biol Chem; 1998 Dec; 273(52):35118-25. PubMed ID: 9857047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.
    Mahnke-Zizelman DK; D'cunha J; Wojnar JM; Brogley MA; Sabina RL
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):521-9. PubMed ID: 9291127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of AMP deaminase 1 binding to myosin heavy chain.
    Hisatome I; Morisaki T; Kamma H; Sugama T; Morisaki H; Ohtahara A; Holmes EW
    Am J Physiol; 1998 Sep; 275(3):C870-81. PubMed ID: 9730972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L.
    Haas AL; Sabina RL
    Biochem Biophys Res Commun; 2003 May; 305(2):421-7. PubMed ID: 12745092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.
    Ronca F; Raggi A
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and inhibition of in vitro proteolysis of human AMPD2 (isoform L) recombinant enzymes.
    Haas AL; Sabina RL
    Protein Expr Purif; 2003 Feb; 27(2):293-303. PubMed ID: 12597889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E.
    Mahnke-Zizelman DK; Sabina RL
    J Biol Chem; 2002 Nov; 277(45):42654-62. PubMed ID: 12213808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
    Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
    Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of adenosine monophosphate deaminase of Candida albicans.
    Thompson A; Hall C; Karunakaran T; Gunasekaran M
    Microbios; 1998; 96(385):133-9. PubMed ID: 10399342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human AMP deaminase 2 (AMPD2) gene expression reveals alternative transcripts encoding variable N-terminal extensions of isoform L.
    Van den Bergh F; Sabina RL
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):401-10. PubMed ID: 8526848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AMPD genes and urate metabolism].
    Morisaki H; Morisaki T
    Nihon Rinsho; 2008 Apr; 66(4):771-7. PubMed ID: 18409530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
    Fortuin FD; Morisaki T; Holmes EW
    Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of AMP deaminase by phosphoinositides.
    Sims B; Mahnke-Zizelman DK; Profit AA; Prestwich GD; Sabina RL; Theibert AB
    J Biol Chem; 1999 Sep; 274(36):25701-7. PubMed ID: 10464307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a noncatalytic domain in AMP deaminase that influences binding to myosin.
    Marquetant R; Sabina RL; Holmes EW
    Biochemistry; 1989 Oct; 28(22):8744-9. PubMed ID: 2605218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site.
    Mangani S; Benvenuti M; Moir AJ; Ranieri-Raggi M; Martini D; Sabbatini AR; Raggi A
    Biochim Biophys Acta; 2007 Feb; 1774(2):312-22. PubMed ID: 17254852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymes of adenylate metabolism and their role in hibernation of the white-tailed prairie dog, Cynomys leucurus.
    English TE; Storey KB
    Arch Biochem Biophys; 2000 Apr; 376(1):91-100. PubMed ID: 10729194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.